@article{04749ee51392462dae799a45094c6886,
title = "Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance",
abstract = "The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.",
author = "Tara Cochrane and Campbell, {Belinda A.} and Gangatharan, {Shane A.} and Maya Latimer and Richard Khor and Christie, {David R.H.} and Michael Gilbertson and Sumita Ratnasingam and Emma Palfreyman and Lee, {Hui Peng} and Judith Trotman and Mark Hertzberg and Michael Dickinson",
note = "Funding Information: Conflict of interest: T. Cochrane: Honoraria – Celgene. S. A. Gangatharan: received conference registration funding from AstraZeneca and Roche. Advisory board for AstraZeneca. MJD: advisory boards for MSD and Takeda, Research funding from MSD. Publisher Copyright: {\textcopyright} 2021 Royal Australasian College of Physicians.",
year = "2021",
month = dec,
doi = "10.1111/imj.15503",
language = "English",
volume = "51",
pages = "2119--2128",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "12",
}